Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI)	Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder	Active, not recruiting	Phase 2	2026-05-28		NCT04568616

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Dartmouth-Hitchcock Medical Center	104

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Dartmouth Hitchcock Medical Center	Lebanon	United States	79
Dartmouth-Hitchcock Medical Center	Lebanon	United States	86

Clinical trials